FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 113 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,684,514 | +40.4% | 2,406,422 | +4.3% | 0.02% | +41.2% |
| Q2 2023 | $7,611,193 | +47.8% | 2,306,422 | +27.7% | 0.02% | +41.7% |
| Q1 2023 | $5,148,303 | -36.9% | 1,806,422 | +61.3% | 0.01% | -40.0% |
| Q4 2022 | $8,153,600 | -23.6% | 1,120,000 | -15.2% | 0.02% | -23.1% |
| Q3 2022 | $10,679,000 | +707.2% | 1,320,000 | +388.9% | 0.03% | +766.7% |
| Q2 2022 | $1,323,000 | -97.1% | 270,000 | -86.2% | 0.00% | -96.6% |
| Q1 2022 | $46,118,000 | +51.6% | 1,950,000 | +13.4% | 0.09% | +60.0% |
| Q4 2021 | $30,427,000 | -8.6% | 1,720,000 | +45.8% | 0.06% | -16.7% |
| Q3 2021 | $33,288,000 | – | 1,180,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $32,054,000 | 14.00% |
| TRV GP IV, LLC | 2,343,154 | $18,956,000 | 11.08% |
| Logos Global Management LP | 1,950,000 | $15,776,000 | 1.94% |
| COWEN AND COMPANY, LLC | 2,347,989 | $18,995,000 | 1.82% |
| VR Adviser, LLC | 1,200,000 | $9,708,000 | 1.50% |
| RA Capital Management | 7,000,000 | $56,630,000 | 1.21% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,528,000 | $28,542,000 | 1.18% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $1,780,000 | 0.77% |
| RTW INVESTMENTS, LP | 3,985,910 | $32,246,000 | 0.74% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $211,000 | 0.69% |